Volume 64, Issue 2 pp. 311-314
Brief Report

IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10

Lei Chen

Lei Chen

Department of Pathology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Search for more papers by this author
Lika'a Fasih Y. Al-Kzayer

Lika'a Fasih Y. Al-Kzayer

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

Search for more papers by this author
Tingting Liu

Corresponding Author

Tingting Liu

Department of Pediatric Hematology/Oncology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Correspondence

Tingting Liu, Department of Hematology/Oncology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Kongjiang Road 1665, Shanghai 200092, China.

Email: [email protected]

Search for more papers by this author
Norimoto Kobayashi

Norimoto Kobayashi

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

Search for more papers by this author
Yozo Nakazawa

Yozo Nakazawa

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

Search for more papers by this author
Kenichi Koike

Kenichi Koike

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

Search for more papers by this author
First published: 12 September 2016
Citations: 16

Abstract

IRF4/MUM1-positive lymphoma is a new subgroup of germinal center-derived B-cell lymphoma, predominantly involving the Waldeyer ring (WR) in children. CD5 expression is rare in these lymphomas. We report a 7-year-old Chinese male with B-cell lymphoma. Evaluation of his specimen by morphology, immunohistochemistry, and FISH analysis demonstrated IRF4/MUM1-positive lymphoma with strong and extensive CD5 and CD10 positivity. Despite the lack of t(14;18)(q32;q21) rearrangement, BCL2 protein was expressed. Our report highlights the clinicopathologic features of IFR4/MUM1-positive lymphoma in WR with co-expression of CD5 and CD10, and thereby provides insight into this newly recognized disease entity.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.